The document discusses coronavirus (COVID-19). It defines coronavirus and describes its structure. COVID-19 was discovered in China in December 2019 and has since spread worldwide. Symptoms include fever, cough, shortness of breath. It is transmitted through droplets from coughing/sneezing of infected individuals. At risk groups include the elderly and those with pre-existing medical conditions. Treatment focuses on supportive care and prevention emphasizes handwashing, social distancing and covering coughs.

1. CORONA VIRUS
PRESENTED BY
Suma. K
Principal
SVP MVP Institute of Nursing Sciences
Hubballi

2. INTRODUCTION
The name "coronavirus" is
derived from Latin corona,
meaning "crown" or "wreath“.

3. STRUCTURE
• Coronaviruses are
large, roughly spherical
particles with bulbous
surface projections.[42]
The average diameter of
the virus particles is
around 125 nm (.125
μm). The diameter of the
envelope is 85 nm and
the spikes are 20 nm
long.

5. WHAT IS
CORONA VIRUS
• A coronavirus is a kind of
common virus that causes
an infection in nose,
sinuses, or upper throat.
Most coronaviruses aren't
dangerous.

6. • A Corona virus was discovered in the year 2019
December in china.
• The World Health Organization identified
SARS-CoV-2 as a new type of coronavirus.
• The outbreak quickly spread around the world
• SARS-CoV-2 is one of seven types of
coronavirus, including the ones that cause severe
diseases like Middle East respiratory syndrome
(MERS) and sudden acute respiratory syndrome
(SARS).
• The other coronaviruses cause most of the colds
that affect us during the year but aren’t a serious
threat for otherwise healthy people.

7. INCIDENCE
• The coronavirus disease (COVID-19)
has been identified as the cause of an
outbreak of respiratory illness in
Wuhan, Hubei Province, China
beginning in December 2019.As of
August 7 2020, this epidemic had
spread to 213 countries
territories around the world and 2
international conveyances with
19,823,512 confirmed cases, including
729,891 deaths.

8. RISK
FACTORS
• Anyone can get COVID-19, and
most infections are mild. The older
you are, the higher your risk of
severe illness.
• You also a have higher chance of
serious illness if you have one of
these health conditions:
• Chronic kidney disease
• Chronic obstructive pulmonary
disease (COPD)

9. • A weakened immune system because of an
organ transplant
• Obesity
• Serious heart conditions such as heart failure
or coronary artery disease
• Sickle cell disease
• Type 2 diabetes
INCUBATION PERIOD : 14 Days
asymptomatic

10. MODE OF
TRANSMISSION
Human corona virus most spread from
an infected person to other through
 The air by coughing and sneezing
Close personal contact, such as
touching and shaking hand.
Touching an object or surface with
the virus on it, then touching your
mouth, nose or eyes before washing
your hands.

13. PATHOPHYSIOLOGY

14. SIGNS AND
SYMPTOMS

16. DIAGNOSIS
• Travel history to endemic countries like
(China, Iran & Italy)
• CBC : Leukopenia, seen in 30% to
45% of patients, and lymphocytopenia,
seen in 85% of the patients)
• Chest X-Ray.
• Chest CT Scan
• IgM/IgG combo test for COVID-19

17. • RTCPR or Nucleic acid amplification test (NAAT) with a sample
collected from the upper respiratory tract

18. MANAGEMENT
• No specific treatment for COVID-19 is
currently available. Clinical management
includes prompt implementation of
recommended infection prevention and
control measures and supportive
management of complications, including
advanced organ support if indicated.

19. 1. Mild cases: Supportive treatments (Antihistamine &
Analgesics)
2. Moderate cases: a. Oseltamivir (150 mg BID for 5 days)
b. Hydroxychloroquine, Chloroquine (500 mg BID )for 14
days or Ribavirin for 5 days
3. Severe cases:
a. Oseltamivir (150 mg BID for 5 days)
b. Kaletra (Lopinavir/Ritonavir) for 5 days
c. Hydroxychloroquine, Chloroquine (500 mg BID for 14
days) or Ribavirin (for 5 days)
4. Critical cases:
a. Oseltamivir 150 mg BID for 5 days
b. Kaletra (Lopinavir/Ritonavir) for 5 days
c. Ribavirin for 5 days
d. Hydroxychloroquine or Chloroquine for 14 days

20. PREVENTION
1
Wash your hands
often with soap
and water or
clean them with
an alcohol-based
sanitizer.
2
Practice social
distancing.
3
Cover your nose
and mouth in
public.
4
Don’t touch your
face.
5
Clean and
disinfect.

21. DO’S AND DONT’S
DO’S
• Cover your nose and mouth with
disposable tissue or
handkerchiefs while coughing or
sneezing
• Frequently wash hands with soap
and water
• Avoid crowded places.
• Maintain social distancing.
• Drink plenty of water or liquids
and eat nutritious food.
DONT’S
• Touching eyes, nose and mouth
with unwashed hands.
• Hugging, kissing and shaking
hands while greeting.
• Spitting in public places.
• Disposal of used napkin or tissue
papers in open areas.
• Touching surfaces usually used
by public places.

22. PROPHYLAXIS

24. NURSING
MANAGEMENT
1. House to house surveillance
including
 Identification of probable
cases and early reporting
Provide psychosocial care and
stigma and discrimination
2. Community awareness through
interpersonal communication.
3. Promote preventive and control
measure including social
distancing, home care and home
quarantine.
4. Reporting and feed back.
5. Personal safety and precautions.

25. • Physical examination. Patients who have fever, cough, and shortness
of breath.

26. NURSING
DIAGNOSIS
• Infection related to failure to avoid pathogen
secondary to exposure to COVID-19.
• Deficient knowledge related to unfamiliarity
with disease transmission information.
• Hyperthermia related to increase in
metabolic rate.
• Impaired breathing pattern related to
shortness of breath.
• Anxiety related to unknown etiology of the
disease.